| Views | |
|---|---|
| A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report | 66 |
| November 2024 | December 2024 | January 2025 | February 2025 | March 2025 | April 2025 | May 2025 | |
|---|---|---|---|---|---|---|---|
| A distinctive bullous skin reaction associated with enfortumab vedotin‐ejfv treatment for metastatic urothelial cancer: A case report | 1 | 1 | 3 | 2 | 2 | 0 | 0 |
| Views | |
|---|---|
| 2021_Krause_etal.pdf | 176 |
